Corrigendum to ‘Identification of a RNA-seq-based signature to improve prognostics for uterine sarcoma’ [Gynecologic Oncology 155 (2019) 499–507]

The authors regret there was an error in Fig. 3. The correct version can be found below, and the online version has been updated. DOI of original article: 10.1016/j.ygyno.2019.08.033 Identification of a RNA-seq-based signature to improve prognostics for uterine sarcomaGynecologic OncologyVol. 155Issue 3PreviewUterine sarcoma (US) is a highly malignant cancer with poor prognosis and high mortality. This study focused on the identification of a RNA-Seq expression signature for prognosis prediction in uterine sarcoma. Full-Text PDF